Applying 4 philosophies to the nurse case manager role can assist with patient decision making.
Mary Ann Caputo, executive director, Support for People with Oral and Head and Neck Cancer (SPOHNC), discusses services offered by the foundation for patients, caregivers, and their families.
From long-term data to additional clinical trials, more is needed to better understand immunotherapy in lung cancer.
The occurence of hand-foot skin response could signal regorafenib activity in hepatocellular cancer.
James L. Klosky, PhD, director or psychological services and cancer survivorship, St. Jude Children’s Research Hospital, discusses HPV-related complications, including cancer, for survivors of childhood cancer.
Although we as healthcare providers want to be cautious and not provide a sense of false hope, we can also acknowledge that for individuals who are deeply religious and spiritual, terminal illness that results in death may not be viewed as negative.
Ian R. Kleckner, PhD, Research Assistant Professor at University of Rochester Medical Center, discusses the benefits of exercise for patients with chemotherapy-induced peripheral neuropathy (CIPN).
About 60% of adult patients with cancer experience constipation, but oncology nurses can help.
Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the universality of psychosocial concerns following a cancer diagnosis.
Jacquelyn Lauria, RN, MSN, APN-C, AOCNP, Advanced Practice Nurse, Stacey Goldstein Breast Cancer Center, Rutgers Cancer Institute of New Jersey, discusses the importance of including a cancer survivor's primary care doctor in the survivorship care plan.
Improvements in cancer treatment have increased survival rates, and with more patients being diagnosed with cancer, complexity of disease state, and treatment toxicity, it can be challenging to identify an appropriate care delivery model.
K. Kelly Hancock, MSN, RN, NE-BC, Executive Chief Nursing Officer, Cleveland Clinic Health System, discusses coordination of care by nurse navigators.
Do a head-to-toe scan when discussing adverse events for melanoma treatment, says a nurse practitioner.
Research shows that not addressing the contributing factors of financial toxicity creates distress, anxiety, and depression and threatens a patient’s optimum health.
Dr. Jeffrey Weber describes the organ-specific side effects that can occur in a patient on checkpoint inhibitors.
Following a high rate of CDIs, the inpatient medical oncology unit at the University of California, Los Angeles, Santa Monica Medical Center adapted an evidence-based intervention.
Louise Eaton, RN, BSN, OCN, inpatient Stem Cell Transplant Unit, John Theurer Cancer Center, provides advice for the relationship between caregivers and patients undergoing stem cell transplantation, as well as responsibilities for caregivers.
Mikel Ross discusses the different costs of cooling cap interventions for chemotherapy-induced hair loss and insurance coverage.
Richard Joseph, MD, an oncologist at Mayo Clinic, discusses mucosal melanoma.
Research is focusing more on the realities of a cystectomy and how to improve treatment options.
Kathrin Milbury, PhD, assistant professor of Integrative Medicine Research at The University of Texas MD Anderson Cancer Center, discusses the importance of spouse and caregiver self care when tending to someone with lung cancer.
Complementary therapies in cancer care are on the rise. With their hospital's blessing and support, 2 nurses have been providing free Reiki to patients for 10 years as part of their approach to care.
The addition of albumin-bound paclitaxel (nab-paclitaxel) to the treatment standard gemcitabine significantly lengthened survival in patients with metastatic pancreatic cancer
The MMRF was honored for the 15th year for outstanding stewardship of donors’ funds.
Steven M. Horwitz, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses some new treatments on the horizon for T-cell lymphoma.
Pediatric patients with ALL can expect therapies to help target their disease after they relapse, but experts are looking to combat the disease in the frontline before that.
Sheila Hunt, RN, Baylor Scott and White McClinton Cancer Center, discusses how she manages day-to-day stress as an oncology nurse.